Risk Factors for Osteoporosis among Patients with Inflammatory Bowel Disease-Do We Already Know Everything?

被引:12
作者
Lewandowski, Konrad [1 ]
Kaniewska, Magdalena [1 ]
Wiecek, Martyna [1 ]
Szwarc, Paulina [1 ]
Panufnik, Paulina [1 ]
Tulewicz-Marti, Edyta [1 ]
Walicka, Magdalena [2 ,3 ]
Franek, Edward [2 ,3 ]
Rydzewska, Grazyna [1 ,4 ]
机构
[1] Minist Inferior & Adm, Natl Med Inst, Inflammatory Bowel Dis Unit, Clin Dept Internal Med & Gastroenterol, PL-02507 Warsaw, Poland
[2] Minist Inferior & Adm, Natl Med Inst, Dept Internal Med Endocrinol & Diabetol, PL-02507 Warsaw, Poland
[3] Polish Acad Sci, Mossakowski Med Res Inst, PL-02106 Warsaw, Poland
[4] Jan Kochanowski Univ, Coll Medicum, PL-25317 Kielce, Poland
关键词
metabolic bone disease; inflammatory bowel diseases; osteoporosis; vitamin D; physical activity; ALTERED BONE METABOLISM; CROHNS-DISEASE; ULCERATIVE-COLITIS; MINERAL DENSITY; FRACTURE RISK; GUIDELINES;
D O I
10.3390/nu15051151
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Introduction: There are many known risk factors for osteoporosis (OST) among patients with inflammatory bowel disease (IBD), one of which is physical activity. Material and methods: The aim of the study is to assess the frequency and risk factors of OST among 232 patients with IBD compared to a group of 199 patients without IBD. The participants underwent dual-energy X-ray absorptiometry, laboratory tests, and completed a questionnaire about their physical activity. Results: It was found that 7.3% of IBD patients suffered from OST. Male gender, ulcerative colitis, extensive inflammation in the intestine, exacerbation of disease, rare physical activity, other forms of physical activity, past fractures, lower levels of osteocalcin, and higher levels of C-terminal telopeptide of type 1 collagen were risk factors for OST. As many as 70.6% of OST patients were rarely physically active. Conclusions: OST is a common problem in IBD patients. OST risk factors differ significantly between the general population and those with IBD. Modifiable factors can be influenced by patients and by physicians. The key to OST prophylaxis may be regular physical activity, which should be recommended in clinical remission. It may also prove valuable to use markers of bone turnover in diagnostics, which may enable decisions regarding therapy.
引用
收藏
页数:13
相关论文
共 31 条
[1]   Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density [J].
Abreu, MT ;
Kantorovich, V ;
Vasiliauskas, EA ;
Gruntmanis, U ;
Matuk, R ;
Daigle, K ;
Chen, S ;
Zehnder, D ;
Lin, YC ;
Yang, H ;
Hewison, M ;
Adams, JS .
GUT, 2004, 53 (08) :1129-1136
[2]   Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis [J].
Ardizzone, S ;
Bollani, S ;
Bettica, P ;
Bevilacqua, M ;
Molteni, P ;
Porro, GB .
JOURNAL OF INTERNAL MEDICINE, 2000, 247 (01) :63-70
[3]  
Camacho PM, 2020, ENDOCR PRACT, V26, P1, DOI 10.4158/GL-2020-0524SUPPL
[4]   Role of vitamin K2 in bone metabolism: a point of view and a short reappraisal of the literature [J].
Capozzi, A. ;
Scambia, G. ;
Migliaccio, S. ;
Lello, S. .
GYNECOLOGICAL ENDOCRINOLOGY, 2020, 36 (04) :285-288
[5]   PLASMA-LEVELS AND INTESTINAL-ABSORPTION OF 25-HYDROXYVITAMIN-D IN PATIENTS WITH SMALL BOWEL RESECTION [J].
COMPSTON, JE ;
CREAMER, B .
GUT, 1977, 18 (03) :171-175
[6]   Guidelines for the management of ulcerative colitis. Recommendations of the Working Group of the Polish National Consultant in Gastroenterology and the Polish Society of Gastroenterology [J].
Eder, Piotr ;
Lodyga, Michal ;
Lykowska-Szuber, Liliana ;
Bartnik, Witold ;
Durlik, Marek ;
Gonciarz, Maciej ;
Klopocka, Maria ;
Linke, Krzysztof ;
Malecka-Panas, Ewa ;
Radwan, Piotr ;
Rydzewska, Grazyna .
PRZEGLAD GASTROENTEROLOGICZNY, 2013, 8 (01) :1-20
[7]   Vitamin D in inflammatory bowel disease: more than just a supplement [J].
Gubatan, John ;
Moss, Alan C. .
CURRENT OPINION IN GASTROENTEROLOGY, 2018, 34 (04) :217-225
[8]   Bone density reduction in patients with Crohn disease and associations with demographic and disease variables: Cross-sectional data from a population-based study [J].
Haugeberg, G ;
Vetvik, K ;
Stallemo, A ;
Bitter, H ;
Mikkelsen, B ;
Stokkeland, M .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2001, 36 (07) :759-765
[9]   Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: A population based study [J].
Jahnsen, J ;
Falch, JA ;
Aadland, E ;
Mowinckel, P .
GUT, 1997, 40 (03) :313-319
[10]   Executive summary of the European guidance for the diagnosis and management of osteoporosis in postmenopausal women [J].
Kanis, J. A. ;
Cooper, C. ;
Rizzoli, R. ;
Reginster, J. -Y. .
CALCIFIED TISSUE INTERNATIONAL, 2019, 104 (03) :235-238